TIS 0.00% 0.0¢ tissue therapies limited

From this report: The cash position of the Company is under...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 264 Posts.
    lightbulb Created with Sketch. 3
    From this report:
    The cash position of the Company is under constant review by the Board and the Board is considering its options to ensure that cash resources are in place through to the commencement of sales.

    One of the options is, of course, (continue!!!) to pay the consultants via shares. The service provided by those consultants has never been detailed as has the method of conversion of (consultant's) invoice value into shares issued.
    This method of dealing with services rendered is highly questionable IMO and indicates that TIS is in a cash-strapped position that is only going to get worse with first sales revenue now expected to be in late 1Q 2015. .   Remember: the cash payment(s) due to QUT are of paramount importance - I don't think QUT will take shares for its services rendered.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.